Puerto Rico HIV
Meeting category
Date(s)
23 Aug 2019 - 24 Aug 2019
Location
San Juan, Puerto Rico
9 CME credits
Organizer

Puerto Rico Meeting on Hepatitis & HIV 2019

Related Enduring Materials

Enduring Materials

23 August 2019

- 14:00
14:00 AST
Welcome and Opening
Jorge Santana-Bagur, MD
University 0f Puerto Rico, Puerto Rico
Session 1: Keynote Lectures -
Chairs
Jorge Santana-Bagur, MD
University 0f Puerto Rico, Puerto Rico
Pablo Tebas, MD
University of Pennsylvania, United States of America
14:15 AST
Starting HAART in 2019: When and How
Pedro Cahn, MD, PhD
Fundación Huésped Buenos Aires, Argentina
14:35 AST
Global Challenges in Hepatitis B Treatment
Iván Antúnez, MD
University of Puerto Rico, Puerto Rico
14:55 AST
Hepatitis C Elimination: Is It Possible?
Andrea Cox, MD
Johns Hopkins School of Medicine, United States
Session 2: HIV-Related Session -
Chairs
Mauro Schechter, MD, PhD
Federal University of Rio de Janeiro, Brazil
Vivian Tamayo
PRCONCRA
16:15 AST
Challenges with the Implementation of PrEP
Kenneth H. Mayer, MD
The Fenway Institute, United States
16:35 AST
The Puerto Rican Experience - Discussion
17:00 AST
PEP After Sexual Exposures
Mauro Schechter, MD, PhD
Federal University of Rio de Janeiro, Brazil
17:20 AST
New ARVs/New Strategies
Pablo Tebas, MD
University of Pennsylvania, United States of America

24 August 2019

Session 3: Viral Hepatitis-Related -
Chairs
Iván Antúnez, MD
University of Puerto Rico, Puerto Rico
Pedro Cahn, MD, PhD
Fundación Huésped Buenos Aires, Argentina
08:30 AST
Local Situation in Puerto Rico: Epidemiology and Treatment Options
Jorge Santana-Bagur, MD
University 0f Puerto Rico, Puerto Rico
09:00 AST
DDA's Paradigm in HCV Treatment
placeholder3
David Kershenobich Stalnikowitz, MD, Phd
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico
09:30 AST
HCV Treatment in Renal Impaired Patients
David Roth, MD, PhD
University of Miami Health System, United States
Oral Abstract Presentations -
Chairs
Camila Gelpi-Acosta, PhD
LaGuardia Community College, United States
Angeles Rodríguez, MD, MPH
Department of Health, Puerto Rico
10:45 AST
Acceptability and Concerns Over the Use of PrEP in Puerto Rico
Malave-Rivera
#1
10:55 AST
Hurricane Maria’s Viral Impact: HIV Care Outcomes Among Substance Users in Puerto Rico Following Hurricane Maria
D. Hernández
#2
11:05 AST
The Role of The National HIV Behavioral Surveillance System in Puerto Rico
Rolón Colón
#3
11:15 AST
Associations Between Hepatitis C and Social Determinants of Health in a Sample of Injecting Drug Users Living with HIV in Puerto Rico
Maisonet Alejandro
#4
Session 4: ART in Vulnerable Populations -
Chairs
Carlos Rodriguez-Diaz, PhD
University of Puerto Rico, Puerto Rico
Pablo Tebas, MD
University of Pennsylvania, United States of America
11:35 AST
Problematic Use of Drugs and HIV and Hepatitis Risks in Puerto Rico
Camila Gelpi-Acosta, PhD
LaGuardia Community College, United States
12:05 AST
Treatment and Care with Vulnerable Populations
Amanda Castel, MD
George Washington University, United States
12:35 AST
Clinical Case Presentation(s)
Carlos Rodriguez-Diaz, PhD
University of Puerto Rico, Puerto Rico
Session 5: ART in Special Populations and Comorbidities -
Chairs
Amanda Castel, MD
George Washington University, United States
placeholder3
David Kershenobich Stalnikowitz, MD, Phd
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico
14:00 AST
Prevention and care strategies for the high risk population in Puerto Rico
Carlos Rodriguez-Diaz, PhD
University of Puerto Rico, Puerto Rico
14:30 AST
The Struggles of the Aging (Co-infected) Population
placeholder3
Iván Meléndez-Rivera, MD, FAAFP
Chief Medical Director - Centro Ararat, Inc
15:00 AST
Hepatitis C Issues in Liver Transplantation
José Rivera-Acosta
José Rivera-Acosta, MD
Hospital Auxilio Mútuo, Puerto Rico
Session 6: Future Challenges -
Chairs
Jorge Santana-Bagur, MD
University 0f Puerto Rico, Puerto Rico
Mauro Schechter, MD, PhD
Federal University of Rio de Janeiro, Brazil
16:15 AST
From Long-Acting Antivirals to Functional Cure
Pablo Tebas, MD
University of Pennsylvania, United States of America
16:45 AST
HIV and Viral Hepatitis: Cascade of Care in Puerto Rico
Angeles Rodríguez, MD, MPH
Department of Health, Puerto Rico
17:15 AST
Round Table Discussion: Cascade of Care
17:45 AST
Closing Remarks
Jorge Santana-Bagur, MD
University 0f Puerto Rico, Puerto Rico
Overview
Welcome

On behalf of the Organizing Committee, we wish you a warm welcome to the Puerto Rico Meeting on Hepatitis and HIV. We are delighted to bring you the first combined conference on such important and relevant topics and we hope you might be able to join us in this unique workshop in San Juan, Puerto Rico in August 2019.

Our key goal in establishing this meeting is to bring together practicing physicians and healthcare providers who treat both infections on a day-to-day basis in order to improve quality in clinical practice and to improve patient experience. As part of our overarching goal, we are trying to expand hepatitis C (HCV)/HIV awareness among HIV practitioners, infectious disease physicians, gastroenterologists, and hepatologists, particularly in light of its high prevalence as comorbidities in our local epidemic and other low-resource settings. The scientific topics discussed in the program will cover the latest advances in the fields of diagnosis and management.

The core program has been developed to provide state-of-the-art information on HIV and viral hepatitis and to discuss regional issues and challenges, focusing on public health implications. This meeting offers a selection of plenary sessions and round table case discussions with the aim to stimulate collaborations across key stakeholders to advance the field.

The nature of this meeting and its program will be interactive, stimulating locoregional and cross-disciplinary exchange, in-depth discussion, and debate in order to promote emphasis on future steps in curtailing both epidemics.

Chairs

Practical Information

Certificate of Attendance
A certificate of attendance was sent by e-mail after the workshop.
Language
The official conference language was English.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio and Video Recordings
Photographs as well as audio and video recordings are not permitted at the official workshop sessions. Only the official medical writer, appointed by the organization, may make recordings. All presentations, will be posted on the workshop website as soon as possible after the workshop is finished, provided that the speaker has given permission to do so.
Committees

The members of the Organizing Committee (OC) frequently discuss the scientific program of the workshop, identify interesting topics, and nominate speakers.

Organizing Committee
Support
The educational activity is supported by an educational grant from
Sliver Level
Endorsers